Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Dosimetry”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableUnknownNCT05823402
What this trial is testing

Use of SPECT-CT for Comparison of Dosimetry Methods in PSMA-targeted Radioligand Therapy (SPECTacular Study)

Who this might be right for
Metastatic Castration-resistant Prostate Cancer
BAMF Health 30
Early research (Phase 1)Looking for participantsNCT06343038
What this trial is testing

Targeted Radionuclide Therapy in Metastatic Prostate Cancer Using a New PSMA Ligand Radiolabelled With Terbium-161 (161Tb-SibuDAB) - Dose Identification/Escalation Phase Ia/b Study

Who this might be right for
Castration-resistant Prostate Cancer
University Hospital, Basel, Switzerland 25
Early research (Phase 1)Looking for participantsNCT07197645
What this trial is testing

Samarium Optimized for Long-lasting Analgesia in Cancerous End-stage Bone Pain

Who this might be right for
Bone PainMetastatic Bone TumorBone Metastases in Subjects With Advanced Cancer
Telix Pharmaceuticals (Innovations) Pty Limited 33
Testing effectiveness (Phase 2)UnknownNCT04536454
What this trial is testing

Study to Assess Safety and PET Imaging Characteristics of a Novel Senescence-specific Radiotracer [18F]FPyGal (2-[Fluorine-18]Fluoro-3-pyridinyl-β-D-galactopyranoside)

Who this might be right for
Cancer
University Hospital Tuebingen 32
Not applicableWithdrawnNCT04343495
What this trial is testing

UV and Bluelight Dosimetry

Who this might be right for
Environmental Exposure
Northwestern University
Testing effectiveness (Phase 2)Looking for participantsNCT06395402
What this trial is testing

177Lu-DOTATATE Modified Delivery Based on Individualized Dosimetry

Who this might be right for
Neuroendocrine TumorsNeuroendocrine Tumor Grade 1Neuroendocrine Tumor Grade 2
University of Iowa 120
Early research (Phase 1)Study completedNCT05195879
What this trial is testing

XTR004 Radiotracer in Healthy Volunteers

Who this might be right for
Coronary Artery Disease (CAD)Myocardial Ischemia
Sinotau Pharmaceutical Group 10
Early research (Phase 1)Study completedNCT03902548
What this trial is testing

Initial Investigation of [18F]P16-129 in Alzheimer's Disease Patients and Healthy Volunteers

Who this might be right for
Alzheimer Disease
Five Eleven Pharma, Inc. 14
Not applicableLooking for participantsNCT07370597
What this trial is testing

LUtetium-177 DOsimetry as a Predictive Biomarker of Response in Metastatic Prostate Cancer Patients Treated With PSMA Radioligand THerapy.

Who this might be right for
Prostate Cancer (Adenocarcinoma)
Jules Bordet Institute 110
Not applicableNot Yet RecruitingNCT07669727
What this trial is testing

A Post Approval Study to Evaluate Safety and Effectiveness of Multicompartmental Dosimetry Planning.

Who this might be right for
Hepatocellular Carcinoma (HCC)
Boston Scientific Corporation 140
Not applicableStudy completedNCT06614205
What this trial is testing

Tumor Absorbed Dose-Response Relationship in Patients Treated With 177Lu-DOTATATE for Meningioma

Who this might be right for
Meningioma of Brain
Central Hospital, Nancy, France 11
Very early researchLooking for participantsNCT07439120
What this trial is testing

Safety and Tolerability Study of 68Ga/177Lu-BRP-020063 in Advanced Solid Tumors

Who this might be right for
Urothelial Carcinoma (UC)
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine 10
Early research (Phase 1)UnknownNCT06237491
What this trial is testing

The Safety and Dosimetry Study of 177Lu-LNC1003 Injection

Who this might be right for
Metastatic Castration-resistant Prostate Cancer, mCRPC
Yantai LNC Biotechnology Singapore PTE. LTD. 12
Early research (Phase 1)Looking for participantsNCT07661641
What this trial is testing

[177Lu]Lu-A9-0631 and [225Ac]Ac-A9-0642 With [68Ga]Ga-A9-6217 or [177Lu]Lu-A9-0631 Imaging in GRPR+ Solid Tumors

Who this might be right for
Breast CancerProstate CancerColorectal Cancer+1 more
Alpha-9 Oncology USA Inc. 115
Very early researchNot Yet RecruitingNCT07639970
What this trial is testing

Evaluation of [⁶⁸Ga/¹⁷⁷Lu]HT547: Safety, Biodistribution, and Dosimetry in Solid Tumors

Who this might be right for
Breast CancerHead and Neck Cancer (H&N)Pancreatic Cancer+1 more
Hua Pang 20
Early research (Phase 1)Study completedNCT02629003
What this trial is testing

[11C]Cimbi-36 Dosimetry

Who this might be right for
Healthy
Gitte Moos Knudsen 8
Not applicableUnknownNCT06065969
What this trial is testing

Photobiomodulation Dosimetry s in Patients With Orofacial Pain

Who this might be right for
Orofacial PainTension-Type Headache
University of Nove de Julho 240
Very early researchEnded earlyNCT00725946
What this trial is testing

Pilot Study to Determine Radioiodide Accumulation and Dosimetry in Breast Cancers Using 124I PET/CT

Who this might be right for
Breast CancerBreast Cancer Early Stage Breast Cancer (Stage 1-3)Breast Cancer Metastatic Breast Cancer
Stanford University 7
Not applicableWithdrawnNCT06276946
What this trial is testing

Sparing Parotid Ducts Via MRI Sialography for Reduced Patient Reported Xerostomia

Who this might be right for
Oropharynx CancerHead and Neck CancerXerostomia
UNC Lineberger Comprehensive Cancer Center
Testing effectiveness (Phase 2)Study completedNCT04318561
What this trial is testing

Gallium-68 Labeled LM3 PET/CT in Neuroendocrine Tumors

Who this might be right for
Neuroendocrine Tumors
Peking Union Medical College Hospital 40
Next Page